BMS-986158, a Small Molecule Inhibitor of the Bromodomain and Extraterminal Domain Proteins, in Patients with Selected Advanced Solid Tumors: Results from a Phase 1/2a Trial.

Autor: Hilton, John1 (AUTHOR) jfhilton@toh.ca, Cristea, Mihaela2 (AUTHOR), Postel-Vinay, Sophie3 (AUTHOR), Baldini, Capucine3 (AUTHOR), Voskoboynik, Mark4,5 (AUTHOR), Edenfield, William6 (AUTHOR), Shapiro, Geoffrey I.7 (AUTHOR), Cheng, Michael L.7 (AUTHOR), Vuky, Jacqueline8 (AUTHOR), Corr, Bradley9 (AUTHOR), Das, Sharmila10 (AUTHOR), Apfel, Abraham10 (AUTHOR), Xu, Ke10 (AUTHOR), Kozicki, Martin10 (AUTHOR), Ünsal-Kaçmaz, Keziban10 (AUTHOR), Hammell, Amy10 (AUTHOR), Wang, Guan10 (AUTHOR), Ravindran, Palanikumar10 (AUTHOR), Kollia, Georgia10 (AUTHOR), Esposito, Oriana10 (AUTHOR)
Zdroj: Cancers. Sep2022, Vol. 14 Issue 17, p4079. 19p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje